Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Magnetic Resonance Imaging of the Prostate Combined With a Radiomics Evaluation Determine the Invasive Capacity of a Tumour (Can MRI-PREDICT)

NCT05024162 is registered in ClinicalTrials.gov with Nova Scotia Health Authority as lead sponsor.

NCT NCT05024162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05024162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Magnetic Resonance Imaging of the Prostate Combined With a Radiomics Evaluation Determine the Invasive Capacity of a Tumour (Can MRI-PREDICT)
Lead sponsor
Nova Scotia Health Authority
Phase
Not applicable
Overall status
Recruiting
Start date
January 4, 2022
Completion date
September 1, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer